Company Overview and News

1
GPL / Great Panther Silver Ltd FORM 40-F

2018-03-29 sec.gov
Great Panther Silver Ltd.: Form 40-F - Filed by newsfilecorp.com UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 40-F [ ] REGISTRATION STATEMENT PURSUANT TO SECTION 12 OF THE SECURITIES EXCHANGE ACT OF
Upvote Downvote

 
Newrange Gold Appoints Robert Archer to Board of Directors

2018-03-01 marketwired
VANCOUVER, BC--(Marketwired - March 01, 2018) - (TSX VENTURE: NRG) (OTCQB: NRGOF) (FRANKFURT: X6C) - Newrange Gold Corp. ("Newrange" or the "Company") is pleased to welcome Mr. Robert Archer, Co-founder of Great Panther Silver Limited, as a Director of the Company, effective immediately. Mr. Archer's highly successful career spans more than 37 years in exploration, mining and executive management of resource sector companies.
Upvote Downvote

 
GPL / Great Panther Silver Ltd 6-K (Current Report of Foreign Issuer)

2018-02-28 sec.gov
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the month of February 2018 Commission File Number: 001-35043 GREAT PANTHER SILVER LIMITED (Translation of registrant's name into English) 1330 – 200 Granville Street
 Vancouver, British Columbia, V6C 1S4, Canada (Address of principal executive offices) Indicate by check mark whether the registrant files o
Upvote Downvote

 
Great Panther Silver Limited 2017 Q4 - Results - Earnings Call Slides

2018-02-26 seekingalpha
The following slide deck was published by Great Panther Silver Limited in conjunction with their 2017 Q4 earnings call.
Upvote Downvote

 
Great Panther Silver (GPL) CEO James Bannantine on Q4 2017 Results - Earnings Call Transcript

2018-02-23 seekingalpha
Good morning, ladies and gentlemen, and thank you for standing by. Welcome to Great Panther Silver Limited’s 2017 Year End Financial Results Conference Call and Webcast. As a reminder, all participants are in a listen-only mode and the conference is being recorded. After the presentation, there will be an opportunity to ask questions. [Operator Instructions].
Upvote Downvote

 
BRIEF-Great Panther Silver Says Qtrly Gold Production Increased 14 Pct To 5,931 Ounces

2018-02-23 reuters
* GREAT PANTHER SILVER LTD - ‍Q4 2017 SILVER PRODUCTION INCREASED 12% TO 514,218 SILVER OUNCES VERSUS Q4 2016 ​
Upvote Downvote

 
GPL / Great Panther Silver Ltd FORM 6-K (Current Report of Foreign Issuer)

2018-02-23 sec.gov
      UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM 6-K   REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934   For the month of February 2018   Commission File Number: 001-35043     GREAT PANTHER SILVER LIMITED (Translation of registrant's name into English)   1330 – 200 Granville Street
 Vancouver, British Columbia, V6C 1S4, Canada (Address of principal executive offices)   Indicate by check mark whether
Upvote Downvote

 
GPL / Great Panther Silver Ltd FORM 6-K (Current Report of Foreign Issuer)

2018-02-22 sec.gov
      UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM 6-K   REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934   For the month of February 2018   Commission File Number: 001-35043     GREAT PANTHER SILVER LIMITED (Translation of registrant's name into English)   1330 – 200 Granville Street
 Vancouver, British Columbia, V6C 1S4, Canada (Address of principal executive offices)   Indicate by check mark whether
Upvote Downvote

3
Top 10 Silver Mining Stocks For 2018

2018-02-13 seekingalpha
Above are my Top 10 silver mining stocks for 2018. All of these companies have large resources and are highly undervalued based on their cash flow potential at higher silver prices. They are on this list primarily because of their upside potential. These are all producers except for one development stock (Bear Creek Mining).
Upvote Downvote

 
GPL / Great Panther Silver Ltd / VAN ECK ASSOCIATES CORP - 3G/A (Passive Investment)

2018-02-09 sec.gov
schedule13g.htm     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.7)*     Great Panther Silver Ltd. (Name of Issuer)  COMMON SHARES    (Title of Class of Securities) 39115V101    (CUSIP Number)   December 31, 2017 - Year End Filing  (Date of Event Which Requires Filing of this Statement)   Check the appropriate box to designate the rule pursuant to which this Schedule is filed:   [X] Rule 13d-1(b) [ 
Upvote Downvote

 
GPL / Great Panther Silver Ltd / VAN ECK ASSOCIATES CORP - 3G/A (Passive Investment)

2018-02-09 sec.gov
schedule13g.htm     UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No.7)*     Great Panther Silver Ltd. (Name of Issuer)  COMMON SHARES    (Title of Class of Securities) 39115V101    (CUSIP Number)   December 31, 2017 - Year End Filing  (Date of Event Which Requires Filing of this Statement)   Check the appropriate box to designate the rule pursuant to which this Schedule is filed:   [X] Rule 13d-1(b) [ 
Upvote Downvote

 
GPL / Great Panther Silver Ltd FORM 6-K (Current Report of Foreign Issuer)

2018-02-08 sec.gov
      UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   FORM 6-K   REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934   For the month of February 2018   Commission File Number: 001-35043     GREAT PANTHER SILVER LIMITED (Translation of registrant's name into English)   1330 – 200 Granville Street
 Vancouver, British Columbia, V6C 1S4, Canada (Address of principal executive offices)   Indicate by check mark whether
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...

CUSIP: 39115V101